Syndax stockholders elect directors, approve say-on-pay, ratify auditor at 2022 annual meeting

Syndax Pharmaceuticals Inc

All three director nominees elected: Katkin 27.7M for/16.4M withheld, Morrison 25.4M/18.7M, Podlesak 23.4M/20.7M.
Advisory vote on executive compensation approved: 43.9M for, 227K against, 7.8K abstain.
Stockholders recommended annual say-on-pay frequency (43.4M for 1 year); board adopted annual vote.
Ratification of Deloitte & Touche as auditor: 49.2M for, 17K against, 759 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.